CANQF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Aug 12 closing price
Capitalization
296.11K
CHSYF
Price
$1.35
Change
-$0.17 (-11.18%)
Updated
Aug 1 closing price
Capitalization
4.53B
Interact to see
Advertisement

CANQF vs CHSYF

Header iconCANQF vs CHSYF Comparison
Open Charts CANQF vs CHSYFBanner chart's image
CanaQuest Medical
Price$0.01
Change-$0.00 (-0.00%)
Volume$56K
Capitalization296.11K
China Medical System Holdings
Price$1.35
Change-$0.17 (-11.18%)
Volume$1K
Capitalization4.53B
CANQF vs CHSYF Comparison Chart in %
Loading...
CANQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANQF vs. CHSYF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANQF is a Buy and CHSYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CANQF: $0.01 vs. CHSYF: $1.35)
Brand notoriety: CANQF and CHSYF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CANQF: 107% vs. CHSYF: 48%
Market capitalization -- CANQF: $296.11K vs. CHSYF: $4.53B
CANQF [@Pharmaceuticals: Generic] is valued at $296.11K. CHSYF’s [@Pharmaceuticals: Generic] market capitalization is $4.53B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANQF’s FA Score shows that 0 FA rating(s) are green whileCHSYF’s FA Score has 1 green FA rating(s).

  • CANQF’s FA Score: 0 green, 5 red.
  • CHSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHSYF is a better buy in the long-term than CANQF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANQF’s TA Score shows that 2 TA indicator(s) are bullish while CHSYF’s TA Score has 0 bullish TA indicator(s).

  • CANQF’s TA Score: 2 bullish, 1 bearish.
  • CHSYF’s TA Score: 0 bullish, 3 bearish.
According to our system of comparison, CANQF is a better buy in the short-term than CHSYF.

Price Growth

CANQF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while CHSYF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.53B) has a higher market cap than CANQF($296K). CHSYF YTD gains are higher at: 45.052 vs. CANQF (-30.200).
CANQFCHSYFCANQF / CHSYF
Capitalization296K4.53B0%
EBITDAN/A2.05B-
Gain YTD-30.20045.052-67%
P/E RatioN/A14.06-
RevenueN/A7.86B-
Total CashN/A5.97B-
Total DebtN/A748M-
FUNDAMENTALS RATINGS
CANQF vs CHSYF: Fundamental Ratings
CANQF
CHSYF
OUTLOOK RATING
1..100
4139
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
15
Undervalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
10043
PRICE GROWTH RATING
1..100
8941
P/E GROWTH RATING
1..100
10073
SEASONALITY SCORE
1..100
2718

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHSYF's Valuation (15) in the null industry is in the same range as CANQF (36). This means that CHSYF’s stock grew similarly to CANQF’s over the last 12 months.

CHSYF's Profit vs Risk Rating (88) in the null industry is in the same range as CANQF (100). This means that CHSYF’s stock grew similarly to CANQF’s over the last 12 months.

CHSYF's SMR Rating (43) in the null industry is somewhat better than the same rating for CANQF (100). This means that CHSYF’s stock grew somewhat faster than CANQF’s over the last 12 months.

CHSYF's Price Growth Rating (41) in the null industry is somewhat better than the same rating for CANQF (89). This means that CHSYF’s stock grew somewhat faster than CANQF’s over the last 12 months.

CHSYF's P/E Growth Rating (73) in the null industry is in the same range as CANQF (100). This means that CHSYF’s stock grew similarly to CANQF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANQFCHSYF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
42%
Bullish Trend 1 day ago
9%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
39%
Bullish Trend 1 day ago
9%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
10%
View a ticker or compare two or three
Interact to see
Advertisement
CANQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTVT22.810.63
+2.86%
vTv Therapeutics
PRI274.040.53
+0.19%
PRIMERICA
CNOBP23.82-0.05
-0.21%
ConnectOne Bancorp
MLP18.97-0.21
-1.09%
Maui Land & Pineapple Co
WEN9.16-0.13
-1.40%
Wendy's Company

CANQF and

Correlation & Price change

A.I.dvisor tells us that CANQF and CANN have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANQF and CANN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANQF
1D Price
Change %
CANQF100%
N/A
CANN - CANQF
9%
Poorly correlated
-2.68%
CRLBF - CANQF
7%
Poorly correlated
-12.50%
CPHRF - CANQF
6%
Poorly correlated
+1.30%
CBWTF - CANQF
6%
Poorly correlated
-1.73%
BSPK - CANQF
2%
Poorly correlated
-6.90%
More

CHSYF and

Correlation & Price change

A.I.dvisor tells us that CHSYF and BSPK have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHSYF and BSPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
BSPK - CHSYF
9%
Poorly correlated
-6.90%
CANN - CHSYF
7%
Poorly correlated
-2.68%
CAIHF - CHSYF
0%
Poorly correlated
N/A
CASBF - CHSYF
0%
Poorly correlated
N/A
CANQF - CHSYF
-0%
Poorly correlated
N/A
More